Nutrisystem.com
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • Support on the Diabetes Journey
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Nutrisystem.com
DHTV
Popular
Top Rated

Related Monitoring Videos on Diabetes Health TV

First Look:  New iPhone App for Logging Readings and Much More

Hadi El Heneidi - Agamatrix

First Look: New iPhone App for Logging Readings and Much More

Nipro Diabetes Systems Introduces The Amigo®

Tony Delamaza

Nipro Diabetes Systems Introduces The Amigo®

Continuous Glucose Monitoring with DEXCOM's

Deb Ruppert

Continuous Glucose Monitoring with DEXCOM's "The Seven"

Homepage Archives

Updated 17 hours ago
Spotlight on Supplements

Cinnamon, chromium, and alpha-lipoic acid are dietary supplements that have been studied for diabetes management, but are not commonly found in daily multivitamins. Chromium* and cinnamon have the least supportive evidence of efficacy, while some studies have found alpha-lipoic acid to be promising, at least subjectively, in reducing the discomforts of peripheral neuropathy.

Alpha lipoic acid, or ALA (not to be confused with alpha-linolenic acid, which has the same abbreviation), is a water- and fat-soluble antioxidant produced by the body to assist in energy metabolism. Foods rich in ALA include spinach, broccoli, and brewer's yeast. ALA may increase insulin sensitivity and enhance glucose uptake in the muscle cells of people with type 2 diabetes.

Comments 0 comments - Feb 12, 2012 - * * * * *

Keeping Up With Baby

My son learned to crawl last month. As a part-time stay-at-home dad, I found it both exciting and terrifying. Through crawling, my son has entered a new stage in life. He might have rolled or scooted a few feet before, but now he can see something in another room and make up his mind to go there.

Comments 1 comment - Feb 10, 2012 - * * * * *

Diabetic Amputations Down Significantly Since 1996

Researchers at the Centers for Disease Control and Prevention report that foot and leg amputations decreased dramatically between 1996 and 2008. Over those 12 years, amputations dropped from 11 out of every 1,000 diabetic adults to only four-a decrease of almost 64 percent. Over the same period, however, the number of people officially diagnosed with diabetes tripled.

Comments 0 comments - Feb 9, 2012 - * * * * *

A Children’s Diabetes Fairytale: Princess Shayna’s Invisible Visible Gift

At the age of 15 years, Sheila Glazov's son Joshua was diagnosed with type 1 diabetes. "In 1985," Glazov says, "our family was living in Mammoth Lakes, California. Our little mountain town had a 15-bed hospital that was efficient if you injured yourself skiing, but not if you were looking for appropriate medical care and support for your child who was newly diagnosed with diabetes."

Comments 0 comments - Feb 8, 2012 - * * * * *

The Seasons of Diabetes

Diabetes doesn't confine itself to a single week or month. It's a year-round condition, and each season offers its own challenges and opportunities for those of us with the disease. We should be prepared to change and evolve as the seasons shift--not only to stay healthy, but also to enjoy all the fun that our dynamic world offers.

Comments 1 comment - Feb 7, 2012 - * * * * *

FDA OKs Sale of Combo Drug JANUMET® XR

The FDA has approved US sales of JANUMET® XR, a daily oral treatment for type 2 diabetes that combines sitagliptin and extended-release metformin. The drug is the fourth oral type 2 diabetes treatment introduced by Merck, which also sells JANUVIA, JANUMET, and JUVISYNC.

Comments 0 comments - Feb 6, 2012 - * * * * *

An Inside View of Barley Beta Glucan

Barley has more beta glucan fiber than any other grain, and it has repeatedly established positive clinical results with regard to diabetes control. It not only boosts immune function by supporting macrophages and neutrophils, lowers blood pressure and cholesterol levels, and helps control obesity, but also attenuates postprandial glucose levels, improves insulin sensitivity, and promotes a feeling of satiety.

Comments 6 comments - Feb 5, 2012 - * * * * *

Community-based Obesity and Type 2 Diabetes Prevention Programs for Children

Due to the rising rates of diabetes and other chronic diseases related to obesity, children are expected to have a shorter lifespan than their parents for the first time in modern history. One in every three children aged two to 19 years is overweight or obese, and one-third of all children born in the year 2000 are expected to develop diabetes during their lifetime.

Comments 0 comments - Feb 4, 2012 - * * * * *

FDA Gives Long-Awaited Nod to Amylin’s Bydureon

After several years of delays and setbacks, Amylin Pharmaceuticals has received FDA approval to begin US marketing of BydureonTM. The first once-a-week type 2 therapy to be offered in the US market, Bydureon is expected to be available by February. Amylin says that its wholesale price will be about $4,200 a year.

Comments 2 comments - Feb 3, 2012 - * * * * *

Next Page »  
Nutrisystem.com
©1991-2012 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.